Ad
related to: when will j&j vaccine be available
Search results
IMUNON Reports 2023 Financial Results and Provides Business Update
Morningstar· 18 hours agoConference Call Begins Today at 10:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development ...
13 Hot Stocks to Invest in According to Wall Street Analysts
Insider Monkey via Yahoo Finance· 12 hours agoIn this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street...
Researchers uncover potential treatment targets for Zika virus–related eye abnormalities
Medical Xpress· 11 hours agoA study published in the journal iScience presents crucial insights into the ocular effects of Zika virus infection during pregnancy and offers promising avenues for therapeutic intervention.
Live Updates: Supreme Court Hears Arguments on Abortion Pill Access
New York Times· 3 days agoIf the Supreme Court sides with the plaintiffs and decides to roll back or invalidate F.D.A....
Briefs for March 23, 2024
Register-Star· 6 days agoTo send information to be included in Briefs, email to editorial@registerstar.com; editorial@thedailymail.net; or mail to Register-Star/Daily Mail, Attention: Briefs, 364 Warren St., Unit 1, Hudson, NY 12534; call 518-828-1616.
FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous...
WKBN 27 Youngstown· 2 days agoThe U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical use to relieve pain before, during ...
Everything We Know About the Cancelled Movie, World War Z 2
CBR.com· 3 days agoWhile slated to serve as the sequel to Brad Pitt's World War Z, World War Z 2 was never fully...
Reflecting on 4 years of COVID-19 and Lancaster County's need for a public health department...
Lancaster Online· 5 days agoTHE ISSUE
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoSIOUX FALLS, S.D., March 25, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
CBS 47 Fresno· 7 days agoThroughout 2023, the Company delivered significant milestones in its leading HBV program, driving the development of novel combination treatment regimens for an HBV functional cure while also ...